Continuous flow liquid-phase plasma technology for efficient oil hydrogenation
A novel continuous flow liquid-phase plasma reactor for oil hydrogenation, offering rapid reactions, high conversion rates, and low energy consumption without forming trans fats. Ideal for scaling up biodiesel production.
Overview
The continuous flow liquid-phase plasma technology offers a groundbreaking approach to oil hydrogenation, enhancing the process by directly generating plasma within the gas-liquid reaction stream. This method significantly increases reaction speed and efficiency, enabling partial hydrogenation of oils without the formation of trans fatty acids. The technology is poised to revolutionize the production of biodiesel by offering a more natural and sustainable hydrogenation process.
Technical specifications
Key features:
- Plasma is generated directly inside the gas-liquid reaction stream, facilitating rapid and efficient chemical reactions.
- Capable of processing low conductivity and dielectric liquids, such as pure vegetable oils.
- Allows for precise control over the degree of hydrogenation through adjustable process parameters, including plasma power, oil and hydrogen gas molar ratio, and reactant flow rate.
- Achieves extremely rapid reaction times, high conversion rates, and high product quality.
- Designed for scalability with a small reactor footprint and low energy consumption.
Technology readiness level
This technology is currently at TRL 2, indicating that it is in the early stages of development. Research is ongoing to validate the hypothesis and optimize the process parameters for commercial applicability. Further experiments aim to refine the reactor design and establish its efficacy in producing partially hydrogenated oils without trans fats.
About University of Minnesota
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.
Inquire about this partnering listing
Industry applications
delivered to your inbox.